| Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
| 17/04/2024 | 23h00 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] | NASDAQ:DMAQ | Deep Medicine Acquisition Corporation |
| 10/04/2024 | 23h00 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NASDAQ:DMAQ | Deep Medicine Acquisition Corporation |
| 10/04/2024 | 23h00 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NASDAQ:DMAQ | Deep Medicine Acquisition Corporation |
| 03/02/2024 | 03h59 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NASDAQ:DMAQ | Deep Medicine Acquisition Corporation |
| 03/02/2024 | 03h58 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NASDAQ:DMAQ | Deep Medicine Acquisition Corporation |
| 03/02/2024 | 03h58 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NASDAQ:DMAQ | Deep Medicine Acquisition Corporation |
| 03/02/2024 | 03h57 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NASDAQ:DMAQ | Deep Medicine Acquisition Corporation |
| 31/01/2024 | 22h46 | GlobeNewswire Inc. | TRUGOLF, INC. AND DEEP MEDICINE ACQUISITION CORP. CLOSE BUSINESS COMBINATION; TRUGOLF BECOMES PUBLICLY TRADED COMPANY | NASDAQ:DMAQ | Deep Medicine Acquisition Corporation |
| 25/01/2024 | 23h16 | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business combinations | NASDAQ:DMAQ | Deep Medicine Acquisition Corporation |
| 25/01/2024 | 23h15 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:DMAQ | Deep Medicine Acquisition Corporation |
| 12/01/2024 | 22h15 | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business combinations | NASDAQ:DMAQ | Deep Medicine Acquisition Corporation |
| 12/01/2024 | 22h10 | GlobeNewswire Inc. | TRUGOLF, INC. AND NASDAQ-LISTED SPAC DEEP MEDICINE ACQUISITION CORP. ANNOUNCE FORM S-4 REGISTRATION STATEMENT DECLARED EFFECTIVE BY THE U.S. SECURITIES AND EXCHANGE COMMISSION AND MAILING OF DEFINITIVE PROXY STATEMENT | NASDAQ:DMAQ | Deep Medicine Acquisition Corporation |
| 28/12/2023 | 06h15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | NASDAQ:DMAQ | Deep Medicine Acquisition Corporation |
| 22/12/2023 | 22h10 | Edgar (US Regulatory) | Form PRER14A - Preliminary Proxy Soliciting materials | NASDAQ:DMAQ | Deep Medicine Acquisition Corporation |
| 20/12/2023 | 22h06 | Edgar (US Regulatory) | Form S-4/A - Registration of securities, business combinations: [Amend] | NASDAQ:DMAQ | Deep Medicine Acquisition Corporation |
| 15/12/2023 | 22h55 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements | NASDAQ:DMAQ | Deep Medicine Acquisition Corporation |
| 08/12/2023 | 23h31 | Edgar (US Regulatory) | Form S-4/A - Registration of securities, business combinations: [Amend] | NASDAQ:DMAQ | Deep Medicine Acquisition Corporation |
| 07/12/2023 | 23h13 | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business combinations | NASDAQ:DMAQ | Deep Medicine Acquisition Corporation |
| 07/12/2023 | 23h11 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:DMAQ | Deep Medicine Acquisition Corporation |
| 21/11/2023 | 22h10 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:DMAQ | Deep Medicine Acquisition Corporation |
| 17/11/2023 | 22h25 | Edgar (US Regulatory) | Form S-4/A - Registration of securities, business combinations: [Amend] | NASDAQ:DMAQ | Deep Medicine Acquisition Corporation |
| 13/11/2023 | 22h15 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:DMAQ | Deep Medicine Acquisition Corporation |
| 02/11/2023 | 21h11 | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business combinations | NASDAQ:DMAQ | Deep Medicine Acquisition Corporation |
| 02/11/2023 | 21h10 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:DMAQ | Deep Medicine Acquisition Corporation |
| 14/08/2023 | 22h31 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:DMAQ | Deep Medicine Acquisition Corporation |
| 03/08/2023 | 02h55 | GlobeNewswire Inc. | Deep Medicine Acquisition Corp. Announces its Filing of Registration Statement on Form S-4 in Connection with Merger with TruGolf, Inc. | NASDAQ:DMAQ | Deep Medicine Acquisition Corporation |
| 31/07/2023 | 23h27 | Edgar (US Regulatory) | Form S-4 - Registration of securities, business combinations | NASDAQ:DMAQ | Deep Medicine Acquisition Corporation |
| 24/07/2023 | 22h06 | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business combinations | NASDAQ:DMAQ | Deep Medicine Acquisition Corporation |
| 24/07/2023 | 22h05 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:DMAQ | Deep Medicine Acquisition Corporation |
| 18/07/2023 | 22h10 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:DMAQ | Deep Medicine Acquisition Corporation |